Distal Esophageal Squamous Cell Carcinoma: A Rare, but Possible Localization
Published: 2023-10-10
Page: 127-131
Issue: 2023 - Volume 6 [Issue 1]
Livia Marieta Negoita *
Clinical Department of Gastroenterology, Bucharest Emergency Clinical Hospital, Romania.
Catalin Stefan Ghenea
Clinical Department of Gastroenterology, Bucharest Emergency Clinical Hospital, Romania.
*Author to whom correspondence should be addressed.
Abstract
Aim: To report a rare but possible localization of a distal esophageal squamous cell carcinoma.
Case Presentation: A 71-year-old man with severe progressive dysphagia and epigastric pain for 2 months. Endoscopy revealed normal esophagus up to 37 cm from the dental arch where a tight stenosis that prevents the endoscope from advancing is visualized. The histopathological result revealed squamous cell carcinoma. Tumor Board decided to initiate neoadjuvant chemo-radiotherapy followed by surgery.
Conclusion: Management of patients with esophagus tumors is challenging. Localization of squamous cell carcinoma in the distal esophagus, although rarer, is possible.
Keywords: Esophageal squamous cell carcinoma, dysphagia, biopsy, esophageal stent, esophagectomy
How to Cite
References
CQ. Liu et al, Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040. Thorac. Cancer. 2023;14(1):3–11. DOI:10.1111/1759-7714.14745
Jain S. Dhingra S, Pathology of esophageal cancer and Barrett’s esophagus, Ann. Cardiothorac. Surg. 2017;6(2).
DOI:10.21037/acs.2017.03.06
Zhang HZ, Jin GF, Shen HB, Epidemiologic differences in esophageal cancer between Asian and Western populations. Chinese Journal of Cancer. 2012;31(6). DOI:10.5732/cjc.011.10390
Yang X. et al, Smoking and alcohol drinking in relation to the risk of esophageal squamous cell carcinoma: A population-based case-control study in China. Sci. Rep. vol. 2017;7(1):17249. DOI: 10.1038/s41598-017-17617-2
Tarazi M, Chidambaram S, Markar SR, Risk factors of esophageal squamous cell carcinoma beyond alcohol and smoking, Cancers. 2021;13(5). DOI: 10.3390/cancers13051009
Zhang S, Orita H, Fukunaga T, Current surgical treatment of esophagogastric junction adenocarcinoma. World Journal of Gastrointestinal Oncology. 2019;11(8). DOI:10.4251/wjgo.v11.i8.567
Marom G, Esophageal cancer staging, Thoracic Surgery Clinics. 2022;32(4). DOI: 10.1016/j.thorsurg.2022.06.006
Ueda H. et al. Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer, Oncotarget. 2017;8(46). DOI:10.18632/oncotarget.17925
M. Watanabe et al, Recent progress in multidisciplinary treatment for patients with esophageal cancer, Surgery Today. 2020;50(1). DOI: 10.1007/s00595-019-01878-7
Vasile MI. et al, Update on Endoscopy-Based Imaging Techniques in the Diagnosis of Esophageal Cancer. Curr. Heal. Sci. J. 2017;43(4):295–300. DOI:10.12865/CHSJ.43.04.01
Abbas H, Ghazanfar H, Ul Hussain AN, Baiomi A, Ihimoyan A, atypical presentation of esophageal squamous cell Carcinoma masquerading as diffuse severe Esophagitis, Case Rep. Gastroenterol. 2021;15(2).
DOI:10.1159/000517129
Schlottmann F, Casas MA, Molena D, Evidence-based approach to the treatment of esophagogastric junction tumors, World J. Clin. Oncol. 2022;13(3): 159–167. DOI:10.5306/wjco.v13.i3.159
Kalff MC, Van Berge Henegouwen MI, Gisbertz SS. Textbook outcome for esophageal cancer surgery: An international consensus-based update of a quality measure. Dis. Esophagus. 2021;34(7). DOI:10.1093/dote/doab011
Jin Z, Zhu K, Sun JJ. Zhang, Zhang B, Minimally invasive versus open esophagectomy after neoadjuvant therapy for esophageal cancer: a meta-analysis. J. Cardiothorac. Surg. 2023; 18(1):90.
DOI:10.1186/s13019-023-02180-x
Lordick F, Hölscher AH, Haustermans K, Wittekind C, Multimodal treatment of esophageal cancer. Langenbeck’s Archives of Surgery. 2013;2:398. DOI: 10.1007/s00423-012-1001-1